Industrial sector

Eder Therapeutics

Eder Therapeutics discovers RNA‑targetable genes using whole‑exome sequencing in Québec’s Saguenay founder population, where extreme cardiometabolic phenotypes reveal protective variants with large effect sizes. This Québec‑anchored genetics engine identifies and validates novel targets for RNAi therapeutics across cardiovascular disease and pancreatitis, creating a scalable pipeline of precision medicines.

https://edertx.ca
https://www.linkedin.com/eder-therapeutics

Stay up to date with the latest news on RNA therapies